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Summary Hyperthermic isolated limb perfusion (ILP) (2mg, TNF-alpha and 100mg, melpha-
lan) was performed for an irresectable right thigh desmoid tumor with calf extension in a
49-year-old man. The patient had a history of four resections since the age of 19 years. Local ILP
toxicity appeared with extensive edema and common peroneal neurologic impairment includ-
ing paresis that remained severe 10 months later. One of the most troublesome side effects
of perfusion is peripheral nerve damage, which has been reported at a rate of between 1
and 48% of perfused patients. ILP is an effective treatment in recurrence situations or whereCommon peroneal
nerve
resection threatens loss of function; it, however, requires administration in specialized centers,
progress in standardization and close monitoring to avoid locoregional toxicity, the mechanisms
of which merit further investigation. Emergency compartmental pressure measurement may
indicate fasciotomy, can be of great interest.
© 2009 Elsevier Masson SAS. All rights reserved.DOI of original article:10.1016/j.rcot.2009.10.005.
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hemotherapy using the isolated limb perfusion (ILP) tech-
ique was developed in 1957, originally for the treatment
f malignant melanoma of the limbs [1], then of sarcoma,
nd has recently been applied in desmoid tumor (DT) with
ositive results [2,3]. This is a regional treatment, pro-
ucing a high non-systemic chemotherapy concentration
served.
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Table 1 Acute local toxicity of the isolated limb perfusion (ILP) procedure classiﬁed according to Wieberdink et al. [4].
Grade Classiﬁcation
I No subjective or objective evidence of reaction
II Slight erythema and/or edema
III Considerable erythema and/or edema with some blistering; slightly disturbed motility is possible
IV Extensive epidermolysis and/or obvious damage to the deep tissues, causing deﬁnite functional
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V Reaction which may require amput
n the tumor, but with the risk of acute local complica-
ion of varying severity on the classiﬁcation of Wieberdink
t al. [4] (Table 1), notably affecting nerve and muscle;
his is the focus of the present case-study complicated by
aralysing nerve damage. To be indicated in a non-life-
hreatening context, a procedure must show a low rate of
ssociated morbidity. The iatrogenic physiopathology needs
o be better understood, so that preventive measures can
e developed.bservation
49-year-old man had been operated on at the age of 19
ears, without previous history, for DT of the posterior com-
n
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Table 2 Motor and sensory conduction ﬁndings.
Jan. 23
N R/L
DML
Common peroneal (EDB) < 6 0.0/4.
Common peroneal (TA) 3.4/4.
Common peroneal (PL) 4.2/2.
Tibial < 6.5 5.3/4.
MCV
Common peroneal (EDB) > 40 0.0/45
Common peroneal (TA) > 40 35.2/5
Common peroneal (PL) > 40 50.0/5
Tibial > 40 40.2/4
CMAP
Common peroneal (EDB) > 2 0.0/2.
Common peroneal (TA) > 2 0.4/4.
Common peroneal (PL) > 2 0.9/7.
Tibial > 3 3.3/7.
F wave
Common peroneal < 56 0.0/49
Tibial < 57 53.1/5
SNAP
Sural > 10 0.0/17
Superﬁcial peroneal > 8 0.0/8.
SCV
Sural > 40 0/40
Superﬁcial peroneal > 40 0/41
DLM: distal motor latency (ms); MCV: motor conduction velocity (m/s); C
latency (ms); R: right; L: left; EDB: response on extensor digitorum bre
longus; SNAP: sensory nerve action potential (V); SCV: sensory conduompartmental syndrome
artment of the right thigh. He was reoperated at the age
f 40 for recurrence in the thigh, and again 2 years later,
hen surgery was supplemented by classical radiotherapy
nd radium therapy. At the age of 47, tumor extension to
he popliteal fossa was detected and a fourth ablation was
erformed in 2007, which was unfortunately incomplete.
On 6 December 2007, ILP with extracorporeal circuit
as performed under general anesthesia, for a low-lying
esidual mass rising under the bifurcation of the sciatic
erve, without neurological impact. With a right subcru-
al approach, the external iliac vein and artery branches
ere excluded using clips. A no. 16 arterial cannula was ﬁt-
ed without difﬁculty to the common femoral artery and a
o. 20 venous cannula to the proximal part of the femoral
, 2008 May 5, 2008 Oct. 13, 2008
R/L R/L
8 0.0 0.0/3.7
0 4.2 4.1/5.2
9 4.8 4.4/4.2
7 4.6 6.8/5.8
.3 0.0 0.0/43.6
3.8 38.7 45.6/54.8
8.3 60.2 54.2/55.6
1.0 35.6 40.2/45.2
7 0.0 0.0/3.0
0 0.3 0.7/4.4
3 1.2 0.9/3.7
7 1.5 1.3/6.8
.3 0.0 0.0/51.9
0.0 66.9 66.9/50.2
.3 0.0/12.6 0.0/12.1
1 2.5/9.2 3.7/10.1
0/42 0/47
30/46 31/48
MAP: compound muscle action potential (mV); F: F wave minimal
vis; TA: response on tibialis anterior; PL: response on peroneous
ction velocity (m/s).
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Figure 1 MRI of desmoid tumor of the popliteal fossa (2.5months).
MRI shows a polylobulated, septated, heterogeneous and ill-deﬁned soft tissue mass (67× 48× 71mm), isointense to muscle on axial
T1-weighted images with low signal areas (A). On the sagittal T2-weighted images with fat suppression, there is a hyperintense area
rvilin
s with
u
s
s
t
f
o
p
v
i
d
p
s
n
h
E
o
t
p
a
f
D
D
i
A
n
o
m
n
e
r
Mwhich corresponds to cellular tissue, and patchy nodular and cu
and dense collagen (B). On axial gadolinium-T1-weighted image
edema of adjacent muscles (C).
vein after upstream clamping; however, the cannula was
unable to descend easily in the femoral vein, and a Scarpa
approach was needed to release the artery and vein. The
conﬂuence of the deep and superﬁcial femoral veins was
greatly remodeled and the cannula was able to be slid
down under visual guidance. An Esmarch bandage was then
placed at the root of the limb and strongly tightened using
two Steinman nails in the iliac wing. Flow was satisfactory
(over 300ml/min) and marked albumin could be delivered
in the circuit without leakage. The limb was heated to
38.5—39 ◦C 2mg of tumor necrosis factor (TNF-alpha) was
injected for 25mins, followed by 100mg of melphalan. A 14%
leak required retightening of the Esmarch bandage, which
proved effective without affecting the cannula lumens or
cardiac sphere. The cannulae were rinsed in 5 l saline and
withdrawn and the arteriophlebotomy was closed. Surgery
lasted 2 or 3 hours, with the patient in dorsal decubitus,
and was well tolerated hemodynamically; on awakening,
however, a diffuse soft edema extending to the groin was
found, with general, intense but dull pain (scored up to 6
or 7 out of 10) with moments of paresthesia and numbness
and, especially, total loss of right foot dorsiﬂexion. Mod-
erate CPK (eight times normal) and myoglobinemia (eight
times normal) elevation was observed 48 hours later.
At D50, examination found right common peroneal nerve
lesion (0/5 dorsiﬂexion of foot and toes, 3/5 eversion),
hypoesthesia in the territory of the lateral sural cuta-
neous and sural nerves, with conserved tibial nerve and
proximal muscles. Ankle jerk was conserved. Limb vol-
ume was increased, with persisting soft edema extending
to the popliteal fossa, and long-standing amyotrophy of
the thigh. Electromyography (EMG) conﬁrmed severe com-
mon peroneal nerve damage (predominating in the territory
of the profondus branch) and right sural, without tibial
nerve involvement (Table 2). Biological analysis was nor-
mal, and venous Doppler ruled out phlebitis. Right limb
compartmental pressure at D55 was 27mmHg in the anterior
compartment and 20mmHg in the external compartment.
MRI at 2.5months (Fig. 1) found the same heteroge-
neous formation extending from the popliteal fossa to the
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year hypointense areas which correspond to hypocellular tissue
fat suppression, there is marked peripheral enhancement and
pper part of the calf, taking less contrast medium than the
urrounding tissue; there was a hypersignal in the muscle
tructures, especially of the posterior compartment, due to
he adjuvant treatment. Secondary partial exeresis was per-
ormed at 3.2months to remove a large part of the tumor
f the upper third of the limb, remote from the common
eroneal nerve, which was not visible, but adhering to the
asculonervous axis at the popliteal fossa and along the tib-
al nerve, sacriﬁcing the posterior superﬁcial branch and
amaging the tibial nerve.
At 5months’ follow-up, the patient complained of heel
ain and plantar dysesthesia, with slight recovery of dor-
iﬂexion in the foot and toes, improved eversion and
ormal plantar ﬂexion. The lateral sural cutaneous and sural
ypoesthesia persisted. The soft-part edema had regressed.
MG found moderate new abnormalities in the territory
f the tibial nerve and no signiﬁcant improvement in the
erritory of the peroneal nerve (Table 2). Gabapentin was
rescribed for 3months then stopped as pain was episodic
nd mild; there was no signiﬁcant evolution at 10months’
ollow-up.
iscussion
Ts [5,6] can be classiﬁed as deep ﬁbromatosis develop-
ng from muscle sheath, fascia and aponeurosis ﬁbroblasts.
lthough histologically benign, they can show local malig-
ancy due to their high rate of recurrence. They generally
ccur singly, located in the abdominal wall, intestine or
esenterium, sometimes in association with familial ade-
omatous polyposis (FAP), or, in almost half of cases, in
xtra-abdominal sites: trunk (scapular belt, posterior tho-
ax, buttocks) or limbs (thigh, arm). First described by
cFarlane in 1832, they are very rare: in Finland, inci-
ence was estimated at two to four new cases per million
f the population, or 3% of soft-tissue tumors. Infrequent
efore the age of 10 years, they mainly affect adolescents
nd young adults, with mean age ranging from 20 to 40
ears; females are twice as frequently concerned as males.
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Table 3 Regional and general complications of isolated limb perfusion (ILP).
Series Lejeune Kettelhack Vrouenraets Vrouenraets Knorr Grunhagen
Date 1989 1990 1994 2001 2006 2006
Number of patients 182 102 350 415 101 51
Tumor type M 93 M/9S M M M M/S
Limb (upper/lower) 206 ILP UL (51), LL (247) UL (7), LL (94) UL (4), LL (47)
Regional toxicity (Wieberdink)
I (no adverse reaction) 5.1% 12 (3.4%) 14 (3.4%) 10 (19.6%)
II (mild erythema/edema) 57.1% 64/113 (56.6%) 284 (81.1%) 325 (78.3%) 35 (35%) 31 (60.8%)
III (severe erythema/edema) 35.9% 7 (6.2%) 49 (14%) 71 (17.1%) 6 (6%) 8 (15.7%)
IV (skin necrosis, compartmental syndrome) 2% 1 (0.29%) 3 (0.7%) 4 (4%) 1 (2%)
V (amputation) 3 (1.5%) 0 1 (0.29%) 2 (0.5%) 1 (1%) 1 (2%)
Edema (persistent lymphatic secretion) 156 (76%) 64/113 (56.6%) 35 (35%)
Lymphocele 5 (5%)
Pain 126 (61%)
Peripheral nerve palsy 49 (24 %) 17 (15 %)T 14 (4 %):(10MS) 1 (1 %)
Thrombosis 6A. 7 V
Wound infection 15 (7%) 3.5%
Superﬁcial wound infection 12 (12%)
Deep wound infection 5 (5%)
Systemic toxicity
Anemia 10 (10%) (SR)
Leukopenia 3 (1.5%) 2 6 (6%) (SR) 2 (SR)
Thrombopenia 1 (1%) (SR)
Hepatic 1 (0.5%) 1 (L)
Renal 1 (L)
Infection 13
Procedure
Hyperthermia Yes Yes Yes Yes/no Yes Yes
Melphalan Yes Yes Yes Yes Yes Yes
TNF-alpha Yes (n = 4) No No Yes/No No Yes
Dactinomycin No No No No Yes No
Cisplatinium No Yes No No No No
M: melanoma; S: sarcoma; SR: spontaneous resolution; L: light; A: artery; V: venous; T: transitory; UL: upper limb; LL: lower limb.
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Pathogenesis [5] may involve traumatic, hormonal and espe-
cially genetic factors, notably in the unusual familial forms
with or without FAP (mutation of the adenomatous poly-
posis coli [APC] gene on the long arm of chromosome 5)
[7,8]. Most patients present with an asymptomatic mass,
although pain, deformity and organ dysfunction may occur
due to inﬁltration of surrounding tissue. Death, on the other
hand, is very rare, only occurring if a vital organ is invaded.
Surgery is the attitude of choice, but requires carcino-
logical exeresis, including a layer of surrounding healthy
tissue to guard against recurrence. It is complicated by
the absence of any cleavage plane, and by adherence to
neighboring structures; exeresis must therefore be either
large-scale, entailing functional risk and morbidity, even
amputation, or incomplete, entailing an elevated rate of
recurrence [5]: overall 10-year recurrence is estimated at
77% [3]. Radiotherapy is recommended as an alternative
when surgery is not feasible [5] and, more frequently, as
an adjuvant in case of incomplete resection, although not
in case of recurrence, in which it seems to be less effective
[8].
The interest of treating these benign tumors with
chemotherapy or other hormonal or anti-inﬂammatory
agents or interferon-alpha, on the other hand, is contro-
versial [5]. Grünhagen et al. [3] applied ILP 12 times in 11
patients with DT of the extremities with local extension,
associating TNF and melphalan; the overall response rate
was 75% (two total and seven partial responses), local con-
trol was achieved in 10 cases out of 12 without systemic
toxicity but with slight local toxicity, four patients showing
grade III reaction (Table 1). Lev-Chelouche et al. [2], a few
years earlier, obtained an 83% response rate (33% total and
50% partial) in six non-operable patients, allowing resection
to be performed 6 to 8 weeks later, at the cost of mild and
reversible local complications (grade II in four patients and
grade III in 2). The procedure frequently entails a risk of
grade I—II local complication, less frequently of grade III,
and sometimes even of grades IV and V, as found when it
is used to treat other kinds of neoplasia (Table 3) [9—14];
complications involve the skin (epidermolysis), nerves (sen-
sory and/or motor impairment) or muscles (ranging from
myalgia to rhabdomyolysis, with a risk of acute renal insuf-
ﬁciency or Crush syndrome).
The frequency of neuropathy varies greatly from series
to series, ranging from 1 to 48% [11]. Vrouenraets et al.
[11] reported 14 cases (4%) of prolonged neuropathy which
had not fully resolved at 3 months, including 10 cases of
upper limb involvement following axillary perfusion (20%)
and four of lower limb involvement following iliac perfusion
(2%); the cases were of single or multiple mononeuropa-
thy involving the median, radial, ulnar, sciatic, femoral,
common peroneal or sural, entailing motor or purely sen-
sory disturbance. In eight cases (57%), symptoms showed
slow improvement, resolving fully over a mean 16 months
(median = 7; range: 3 to 43 months); three patients still had
severe neuropathy at 1 year, and the others showed only
slight improvement at 21 months. It is noteworthy that there
were 10 cases of grade II tissue toxicity and four of grade III
but with no compartmental syndrome that was threatening
or requiring treatment. There were no other acute or long-
term complications, 10 patients being treated by classical
and four by lighter hyperthermia.
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Several mechanisms have been suggested to account for
his acute toxicity: excessive cytotoxin tissue concentra-
ion, altered endothelial structure in muscular capillaries
ue to the cytokines (TNF-alpha), an anaphylactic mecha-
ism, complement activation, production of free radicals,
nterstitial edema due to the hyperthermia causing lasting
ymphoedema secondary to perfusion, or increased intra-
ompartmental pressure due to edema [15]. Hohenberger
t al. [15] described the kinetics of the gradual increase
n compartmental pressure, which can reach 90mmHg dur-
ng perfusion, returning to normal (11 to 21mmHg) only
fter 48 hours. Animal models showed that pressure levels
xceeding 30mmHg for 6 to 8 hours are enough to affect
eural conduction speed [16]. Hohenberger agrees that
he pressure increase aggravates the neuromyotoxicity of
hemotherapy, but argues that the spontaneous regression
ormally observed means that fasciotomy is not systemati-
ally indicated, unless pressure exceeds 30—40mmHg at the
nd of procedure and fails to fall. Bandage compression,
hich is less well controlled proximally than distally (i.e.,
n brachial or femoropopliteal perfusion), may thus account
or occasional neuropathy, especially in the brachial plexus,
hich is less well protected by the subcutaneous muscles
nd tissue [11].
In the present case, there was no procedural error but the
ifﬁculty in positioning the venous cannula for ILP length-
ned the ischemia time; this and the tightening of the
smarch bandage to control leakage —even if it had no
pparent effect on the diameter of the perfused vessels—
ay have induced neuroischemia and/or aggravated the
dema, giving rise to a compartmental syndrome, espe-
ially in the lower leg (lesion of the common peroneal
erve or of its anteroexternal compartment branches and
erhaps also of the sural nerve in a superﬁcial posterior
ompartment reduced by the tumor), for which emergency
asciotomy should be considered. Finally, in order to avoid
erious complications which may be tolerable in a malignant
athology such as melanoma but not in benign DT, Knorr et
l. [13] recommend excluding patients with occlusive arte-
ial pathology and maintaining physiological conditions in
he perfusion circuit: perfusate hematocrit between 25 and
0% and as short an ischemia time as possible during cannu-
ation and decannulation. TNF-alpha may enhance response
ates in melanoma treatment, but increases the risk of local
oxicity, due either to the tissue effects of melphalan at
igh temperature or to interaction between high doses of
NF and melphalan [12].
onclusion
LP provides an undeniable contribution to the manage-
ent of DTs of the extremities when resection is impossible
ithout incurring serious loss of function. In this non-life-
hreatening pathology, however, the risk/beneﬁt ratio needs
arefully assessing: the procedure should be performed in an
xperienced center; progress is needed in standardization
notably: perfusate temperature, perfusion time, and type
nd association of cytostatic drugs); and close monitoring is
ecessary during and after the procedure. Preventing serious
cute local complications requires better understanding of
heir mechanisms; in this regard, emergency compartmen-
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